Home Research Past research Past research Share on Print New drug combination turbo charges attack against cancer Survival times have doubled in early testing of this powerful new drug combination for patients with advanced blood cancers. Researchers identify gene that could lead to better understanding of MDS Melbourne researchers have uncovered secrets about bone marrow failure that could enhance understanding of this rare cancer. Novel drug for treatment of Burkitt’s lymphoma This project hopes to identify alternative therapies for people with Burkitt’s lymphoma who do not respond to standard treatment or relapse. Unlocking leukaemia’s genetic secrets Therese Vu is investigating the role of a gene that may play a role in transforming a blood disorder into acute myeloid leukaemia. Boosting the immune system response Dr Stephen Mattarollo is investigating how a new vaccine, combined with front-line therapy, Rituximab, improves outcomes for non-Hodgkin lymphoma patients. Graft v Host disease To help better understand cGVHD, Katie Lineburg is investigating the cellular processes and immune cells involved in driving the disease. Targeting stem cells in myeloproliferative disorders Dr Steven Lane is evaluating a new combination drug therapy for polycythemia vera (PRV). Double discovery – game changer in quest to cure leukaemia Researchers at the Peter MacCallum Cancer Centre (Melbourne) have uncovered vital new leads on how to outsmart the deadly disease. Research project archive An archive of the blood cancer research projects we’ve funded since 2008.